Figure 1 | British Journal of Cancer

Figure 1

From: Phase II study of a triplet regimen in advanced colorectal cancer using methotrexate, oxaliplatin and 5-fluorouracil

Figure 1

Design of drug regimen. One cycle=8 weeks. In the first part of the regimen, patients were given MTX 200 mg m−2 i.v. diluted in 500 ml of D5W, infused in 1 h, days 1 and 15; oxaliplatin 85 mg m−2 given i.v. as a 2-h infusion in 500 ml of D5W followed by FU 600 mg m−2 i.v. bolus, days 2 and 16 along with LV rescue (15 mg) given p.o. q 6 h × 6 doses. In the second part of the cycle, patients were given FU 200 mg m−2 day−1 CI × 3 weeks (from day 29 to 50), modulated by weekly LV (20 mg m−2 i.v. bolus). After 1 week of rest, the second cycle was started on day 57.

Back to article page